Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom.
Omar A Abdel-MannanCeleste ManchoonThomas RossorJustine-Clair SouthinCarmen TurWallace BrownleeSusan ByrneManali ChitreAlasdair ColesRobert ForsythRachel KneenKshitij MankadDipak RamSiobhan WestSukhvir K WrightEvangeline WassmerMing J LimOlga CiccarelliCheryl HemingwayYael Hacohennull nullPublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
This study provides Class IV evidence that newer DMTs (oral or infusions) are superior to injectables (interferon beta/glatiramer acetate) in reducing both clinical relapses and radiologic activity in children with RRMS.